(Q34568554)

3 August 2017

1 reference

title

Clinical management of BRCA1 and BRCA2 mutation carriers. (English)

1 reference

3 August 2017

1 reference

1 reference

Domchek SM

1

1 reference

3 August 2017

Weber BL

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

25

1 reference

3 August 2017

43

1 reference

3 August 2017

5825-5831

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209881

3 August 2017

0 references

cites work

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Improved survival in women with BRCA-associated ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Peritoneal lavage cytology: an assessment of its value during prophylactic oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

The Fanconi anaemia/BRCA pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Biallelic inactivation of BRCA2 in Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

The role of BRCA1 in the cellular response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Parity, Oral Contraceptives, and the Risk of Ovarian Cancer among Carriers and Noncarriers of aBRCA1orBRCA2Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

A genetic epidemiological study of carcinoma of the fallopian tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Occult cancer of the fallopian tube in a BRCA2 germline mutation carrier at prophylactic salpingo-oophorectomy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209881

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209881

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference